+1 (704) 266-3234
+1 (704) 266-3234You are here :
Published on: Jan 2024 | From USD $3660 | Published By: LP INFORMATION INC | Number Of Pages: 158
According to our LPI (LP Information) latest study, the global Oncology Drugs market size was valued at US$ 193150 million in 2023. With growing demand in downstream market, the Oncology Drugs is forecast to a readjusted size of US$ 393100 million by 2030 with a CAGR of 10.7% during review period.
The research report highlights the growth potential of the global Oncology Drugs market. Oncology Drugs are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Oncology Drugs. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Oncology Drugs market.
Cancer is the name given to a group of related diseases characterized by the uncontrolled and excessive growth of abnormal cells. More than 200 different types of cancer have been identified.
When these extra cells form a mass or a solid lump of tissue, it is called a tumor. Most cancers form tumors, but not all do. Tumors may be either benign or cancerous.
Benign tumors do not spread to other parts of the body and are rarely life-threatening. Many breast lumps, for example, are benign. Benign tumors are not cancer.
Malignant tumors crowd out healthy cells, interfere with body functions, and draw nutrients from body tissues. Malignant tumors can also spread to other parts of the body via the blood or lymphatic system, forming satellite tumors, called secondary cancers or metastases. Malignant tumors are cancer.
The industry's leading producers include Roche, Celgene and Novartis, which together account for 35% of their revenues. By region, North America had the highest share of income, at 43%.
Key Features:
The report on Oncology Drugs market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Oncology Drugs market. It may include historical data, market segmentation by Type (e.g., Chemotherapy, Targeted Therapy), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Oncology Drugs market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Oncology Drugs market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Oncology Drugs industry. This include advancements in Oncology Drugs technology, Oncology Drugs new entrants, Oncology Drugs new investment, and other innovations that are shaping the future of Oncology Drugs.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Oncology Drugs market. It includes factors influencing customer ' purchasing decisions, preferences for Oncology Drugs product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Oncology Drugs market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Oncology Drugs market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Oncology Drugs market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Oncology Drugs industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Oncology Drugs market.
Market Segmentation:
Oncology Drugs market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others
Segmentation by application
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory or Lung Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Roche
Celgene
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Merck & Co.
AstraZeneca
Pfizer
Amgen
Eli Lilly
AbbVie
Takeda
Astellas
Ipsen
Sanofi
Bayer
Biogen Idec
Teva
Otsuka
Eisai
Merck KGaA
Gilead Sciences
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Drugs Market Size 2019-2030
2.1.2 Oncology Drugs Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Oncology Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Targeted Therapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Drugs Market Size by Type
2.3.1 Oncology Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Oncology Drugs Market Size Market Share by Type (2019-2024)
2.4 Oncology Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory or Lung Cancer
2.4.6 Others
2.5 Oncology Drugs Market Size by Application
2.5.1 Oncology Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Oncology Drugs Market Size Market Share by Application (2019-2024)
3 Oncology Drugs Market Size by Player
3.1 Oncology Drugs Market Size Market Share by Players
3.1.1 Global Oncology Drugs Revenue by Players (2019-2024)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2019-2024)
3.2 Global Oncology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Oncology Drugs by Regions
4.1 Oncology Drugs Market Size by Regions (2019-2024)
4.2 Americas Oncology Drugs Market Size Growth (2019-2024)
4.3 APAC Oncology Drugs Market Size Growth (2019-2024)
4.4 Europe Oncology Drugs Market Size Growth (2019-2024)
4.5 Middle East & Africa Oncology Drugs Market Size Growth (2019-2024)
5 Americas
5.1 Americas Oncology Drugs Market Size by Country (2019-2024)
5.2 Americas Oncology Drugs Market Size by Type (2019-2024)
5.3 Americas Oncology Drugs Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oncology Drugs Market Size by Region (2019-2024)
6.2 APAC Oncology Drugs Market Size by Type (2019-2024)
6.3 APAC Oncology Drugs Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Oncology Drugs by Country (2019-2024)
7.2 Europe Oncology Drugs Market Size by Type (2019-2024)
7.3 Europe Oncology Drugs Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oncology Drugs by Region (2019-2024)
8.2 Middle East & Africa Oncology Drugs Market Size by Type (2019-2024)
8.3 Middle East & Africa Oncology Drugs Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Oncology Drugs Market Forecast
10.1 Global Oncology Drugs Forecast by Regions (2025-2030)
10.1.1 Global Oncology Drugs Forecast by Regions (2025-2030)
10.1.2 Americas Oncology Drugs Forecast
10.1.3 APAC Oncology Drugs Forecast
10.1.4 Europe Oncology Drugs Forecast
10.1.5 Middle East & Africa Oncology Drugs Forecast
10.2 Americas Oncology Drugs Forecast by Country (2025-2030)
10.2.1 United States Oncology Drugs Market Forecast
10.2.2 Canada Oncology Drugs Market Forecast
10.2.3 Mexico Oncology Drugs Market Forecast
10.2.4 Brazil Oncology Drugs Market Forecast
10.3 APAC Oncology Drugs Forecast by Region (2025-2030)
10.3.1 China Oncology Drugs Market Forecast
10.3.2 Japan Oncology Drugs Market Forecast
10.3.3 Korea Oncology Drugs Market Forecast
10.3.4 Southeast Asia Oncology Drugs Market Forecast
10.3.5 India Oncology Drugs Market Forecast
10.3.6 Australia Oncology Drugs Market Forecast
10.4 Europe Oncology Drugs Forecast by Country (2025-2030)
10.4.1 Germany Oncology Drugs Market Forecast
10.4.2 France Oncology Drugs Market Forecast
10.4.3 UK Oncology Drugs Market Forecast
10.4.4 Italy Oncology Drugs Market Forecast
10.4.5 Russia Oncology Drugs Market Forecast
10.5 Middle East & Africa Oncology Drugs Forecast by Region (2025-2030)
10.5.1 Egypt Oncology Drugs Market Forecast
10.5.2 South Africa Oncology Drugs Market Forecast
10.5.3 Israel Oncology Drugs Market Forecast
10.5.4 Turkey Oncology Drugs Market Forecast
10.5.5 GCC Countries Oncology Drugs Market Forecast
10.6 Global Oncology Drugs Forecast by Type (2025-2030)
10.7 Global Oncology Drugs Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Drugs Product Offered
11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Oncology Drugs Product Offered
11.2.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Oncology Drugs Product Offered
11.3.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Oncology Drugs Product Offered
11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Oncology Drugs Product Offered
11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Information
11.6.2 Merck & Co. Oncology Drugs Product Offered
11.6.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Merck & Co. Main Business Overview
11.6.5 Merck & Co. Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Oncology Drugs Product Offered
11.7.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Oncology Drugs Product Offered
11.8.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Oncology Drugs Product Offered
11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Oncology Drugs Product Offered
11.10.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11.11 AbbVie
11.11.1 AbbVie Company Information
11.11.2 AbbVie Oncology Drugs Product Offered
11.11.3 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 AbbVie Main Business Overview
11.11.5 AbbVie Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Oncology Drugs Product Offered
11.12.3 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Astellas
11.13.1 Astellas Company Information
11.13.2 Astellas Oncology Drugs Product Offered
11.13.3 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Astellas Main Business Overview
11.13.5 Astellas Latest Developments
11.14 Ipsen
11.14.1 Ipsen Company Information
11.14.2 Ipsen Oncology Drugs Product Offered
11.14.3 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Ipsen Main Business Overview
11.14.5 Ipsen Latest Developments
11.15 Sanofi
11.15.1 Sanofi Company Information
11.15.2 Sanofi Oncology Drugs Product Offered
11.15.3 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.15.4 Sanofi Main Business Overview
11.15.5 Sanofi Latest Developments
11.16 Bayer
11.16.1 Bayer Company Information
11.16.2 Bayer Oncology Drugs Product Offered
11.16.3 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.16.4 Bayer Main Business Overview
11.16.5 Bayer Latest Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Information
11.17.2 Biogen Idec Oncology Drugs Product Offered
11.17.3 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.17.4 Biogen Idec Main Business Overview
11.17.5 Biogen Idec Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Drugs Product Offered
11.18.3 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Drugs Product Offered
11.19.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Eisai
11.20.1 Eisai Company Information
11.20.2 Eisai Oncology Drugs Product Offered
11.20.3 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.20.4 Eisai Main Business Overview
11.20.5 Eisai Latest Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Information
11.21.2 Merck KGaA Oncology Drugs Product Offered
11.21.3 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.21.4 Merck KGaA Main Business Overview
11.21.5 Merck KGaA Latest Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Information
11.22.2 Gilead Sciences Oncology Drugs Product Offered
11.22.3 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2019-2024)
11.22.4 Gilead Sciences Main Business Overview
11.22.5 Gilead Sciences Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Oncology Drugs Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Immunotherapy (Biologic Therapy)
Table 5. Major Players of Hormonal Therapy
Table 6. Major Players of Others
Table 7. Oncology Drugs Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Oncology Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 9. Global Oncology Drugs Market Size Market Share by Type (2019-2024)
Table 10. Oncology Drugs Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 11. Global Oncology Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 12. Global Oncology Drugs Market Size Market Share by Application (2019-2024)
Table 13. Global Oncology Drugs Revenue by Players (2019-2024) & ($ Millions)
Table 14. Global Oncology Drugs Revenue Market Share by Player (2019-2024)
Table 15. Oncology Drugs Key Players Head office and Products Offered
Table 16. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Drugs Market Size by Regions 2019-2024 & ($ Millions)
Table 20. Global Oncology Drugs Market Size Market Share by Regions (2019-2024)
Table 21. Global Oncology Drugs Revenue by Country/Region (2019-2024) & ($ millions)
Table 22. Global Oncology Drugs Revenue Market Share by Country/Region (2019-2024)
Table 23. Americas Oncology Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 24. Americas Oncology Drugs Market Size Market Share by Country (2019-2024)
Table 25. Americas Oncology Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 26. Americas Oncology Drugs Market Size Market Share by Type (2019-2024)
Table 27. Americas Oncology Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 28. Americas Oncology Drugs Market Size Market Share by Application (2019-2024)
Table 29. APAC Oncology Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 30. APAC Oncology Drugs Market Size Market Share by Region (2019-2024)
Table 31. APAC Oncology Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 32. APAC Oncology Drugs Market Size Market Share by Type (2019-2024)
Table 33. APAC Oncology Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 34. APAC Oncology Drugs Market Size Market Share by Application (2019-2024)
Table 35. Europe Oncology Drugs Market Size by Country (2019-2024) & ($ Millions)
Table 36. Europe Oncology Drugs Market Size Market Share by Country (2019-2024)
Table 37. Europe Oncology Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 38. Europe Oncology Drugs Market Size Market Share by Type (2019-2024)
Table 39. Europe Oncology Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 40. Europe Oncology Drugs Market Size Market Share by Application (2019-2024)
Table 41. Middle East & Africa Oncology Drugs Market Size by Region (2019-2024) & ($ Millions)
Table 42. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2019-2024)
Table 43. Middle East & Africa Oncology Drugs Market Size by Type (2019-2024) & ($ Millions)
Table 44. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2019-2024)
Table 45. Middle East & Africa Oncology Drugs Market Size by Application (2019-2024) & ($ Millions)
Table 46. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2019-2024)
Table 47. Key Market Drivers & Growth Opportunities of Oncology Drugs
Table 48. Key Market Challenges & Risks of Oncology Drugs
Table 49. Key Industry Trends of Oncology Drugs
Table 50. Global Oncology Drugs Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 51. Global Oncology Drugs Market Size Market Share Forecast by Regions (2025-2030)
Table 52. Global Oncology Drugs Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 53. Global Oncology Drugs Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 54. Roche Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 55. Roche Oncology Drugs Product Offered
Table 56. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 57. Roche Main Business
Table 58. Roche Latest Developments
Table 59. Celgene Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 60. Celgene Oncology Drugs Product Offered
Table 61. Celgene Main Business
Table 62. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 63. Celgene Latest Developments
Table 64. Novartis Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 65. Novartis Oncology Drugs Product Offered
Table 66. Novartis Main Business
Table 67. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 68. Novartis Latest Developments
Table 69. Bristol-Myers Squibb Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 70. Bristol-Myers Squibb Oncology Drugs Product Offered
Table 71. Bristol-Myers Squibb Main Business
Table 72. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 73. Bristol-Myers Squibb Latest Developments
Table 74. Johnson & Johnson Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 75. Johnson & Johnson Oncology Drugs Product Offered
Table 76. Johnson & Johnson Main Business
Table 77. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 78. Johnson & Johnson Latest Developments
Table 79. Merck & Co. Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 80. Merck & Co. Oncology Drugs Product Offered
Table 81. Merck & Co. Main Business
Table 82. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 83. Merck & Co. Latest Developments
Table 84. AstraZeneca Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 85. AstraZeneca Oncology Drugs Product Offered
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 88. AstraZeneca Latest Developments
Table 89. Pfizer Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 90. Pfizer Oncology Drugs Product Offered
Table 91. Pfizer Main Business
Table 92. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 93. Pfizer Latest Developments
Table 94. Amgen Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 95. Amgen Oncology Drugs Product Offered
Table 96. Amgen Main Business
Table 97. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 98. Amgen Latest Developments
Table 99. Eli Lilly Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 100. Eli Lilly Oncology Drugs Product Offered
Table 101. Eli Lilly Main Business
Table 102. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 103. Eli Lilly Latest Developments
Table 104. AbbVie Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 105. AbbVie Oncology Drugs Product Offered
Table 106. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 107. AbbVie Main Business
Table 108. AbbVie Latest Developments
Table 109. Takeda Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 110. Takeda Oncology Drugs Product Offered
Table 111. Takeda Main Business
Table 112. Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 113. Takeda Latest Developments
Table 114. Astellas Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 115. Astellas Oncology Drugs Product Offered
Table 116. Astellas Main Business
Table 117. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 118. Astellas Latest Developments
Table 119. Ipsen Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 120. Ipsen Oncology Drugs Product Offered
Table 121. Ipsen Main Business
Table 122. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 123. Ipsen Latest Developments
Table 124. Sanofi Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 125. Sanofi Oncology Drugs Product Offered
Table 126. Sanofi Main Business
Table 127. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 128. Sanofi Latest Developments
Table 129. Bayer Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 130. Bayer Oncology Drugs Product Offered
Table 131. Bayer Main Business
Table 132. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 133. Bayer Latest Developments
Table 134. Biogen Idec Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 135. Biogen Idec Oncology Drugs Product Offered
Table 136. Biogen Idec Main Business
Table 137. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 138. Biogen Idec Latest Developments
Table 139. Teva Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 140. Teva Oncology Drugs Product Offered
Table 141. Teva Main Business
Table 142. Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 143. Teva Latest Developments
Table 144. Otsuka Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 145. Otsuka Oncology Drugs Product Offered
Table 146. Otsuka Main Business
Table 147. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 148. Otsuka Latest Developments
Table 149. Eisai Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 150. Eisai Oncology Drugs Product Offered
Table 151. Eisai Main Business
Table 152. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 153. Eisai Latest Developments
Table 154. Merck KGaA Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 155. Merck KGaA Oncology Drugs Product Offered
Table 156. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 157. Merck KGaA Main Business
Table 158. Merck KGaA Latest Developments
Table 159. Gilead Sciences Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 160. Gilead Sciences Oncology Drugs Product Offered
Table 161. Gilead Sciences Main Business
Table 162. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 163. Gilead Sciences Latest Developments
List of Figures
Figure 1. Oncology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Drugs Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Oncology Drugs Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Oncology Drugs Sales Market Share by Country/Region (2023)
Figure 8. Oncology Drugs Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Oncology Drugs Market Size Market Share by Type in 2023
Figure 10. Oncology Drugs in Blood Cancer
Figure 11. Global Oncology Drugs Market: Blood Cancer (2019-2024) & ($ Millions)
Figure 12. Oncology Drugs in Breast Cancer
Figure 13. Global Oncology Drugs Market: Breast Cancer (2019-2024) & ($ Millions)
Figure 14. Oncology Drugs in Gastrointestinal Cancer
Figure 15. Global Oncology Drugs Market: Gastrointestinal Cancer (2019-2024) & ($ Millions)
Figure 16. Oncology Drugs in Prostate Cancer
Figure 17. Global Oncology Drugs Market: Prostate Cancer (2019-2024) & ($ Millions)
Figure 18. Oncology Drugs in Respiratory or Lung Cancer
Figure 19. Global Oncology Drugs Market: Respiratory or Lung Cancer (2019-2024) & ($ Millions)
Figure 20. Oncology Drugs in Others
Figure 21. Global Oncology Drugs Market: Others (2019-2024) & ($ Millions)
Figure 22. Global Oncology Drugs Market Size Market Share by Application in 2023
Figure 23. Global Oncology Drugs Revenue Market Share by Player in 2023
Figure 24. Global Oncology Drugs Market Size Market Share by Regions (2019-2024)
Figure 25. Americas Oncology Drugs Market Size 2019-2024 ($ Millions)
Figure 26. APAC Oncology Drugs Market Size 2019-2024 ($ Millions)
Figure 27. Europe Oncology Drugs Market Size 2019-2024 ($ Millions)
Figure 28. Middle East & Africa Oncology Drugs Market Size 2019-2024 ($ Millions)
Figure 29. Americas Oncology Drugs Value Market Share by Country in 2023
Figure 30. United States Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 31. Canada Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 32. Mexico Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 33. Brazil Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 34. APAC Oncology Drugs Market Size Market Share by Region in 2023
Figure 35. APAC Oncology Drugs Market Size Market Share by Type in 2023
Figure 36. APAC Oncology Drugs Market Size Market Share by Application in 2023
Figure 37. China Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 38. Japan Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 39. Korea Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 40. Southeast Asia Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 41. India Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 42. Australia Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 43. Europe Oncology Drugs Market Size Market Share by Country in 2023
Figure 44. Europe Oncology Drugs Market Size Market Share by Type (2019-2024)
Figure 45. Europe Oncology Drugs Market Size Market Share by Application (2019-2024)
Figure 46. Germany Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 47. France Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 48. UK Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 49. Italy Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 50. Russia Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2019-2024)
Figure 52. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2019-2024)
Figure 53. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2019-2024)
Figure 54. Egypt Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 55. South Africa Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 56. Israel Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 57. Turkey Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 58. GCC Country Oncology Drugs Market Size Growth 2019-2024 ($ Millions)
Figure 59. Americas Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 60. APAC Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 61. Europe Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 62. Middle East & Africa Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 63. United States Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 64. Canada Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 65. Mexico Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 66. Brazil Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 67. China Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 68. Japan Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 69. Korea Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 70. Southeast Asia Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 71. India Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 72. Australia Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 73. Germany Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 74. France Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 75. UK Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 76. Italy Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 77. Russia Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 78. Spain Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 79. Egypt Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 80. South Africa Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 81. Israel Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 82. Turkey Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 83. GCC Countries Oncology Drugs Market Size 2025-2030 ($ Millions)
Figure 84. Global Oncology Drugs Market Size Market Share Forecast by Type (2025-2030)
Figure 85. Global Oncology Drugs Market Size Market Share Forecast by Application (2025-2030)
SECONDARY RESEARCH
Secondary Research Information is collected from a number of publicly available as well as paid databases. Public sources involve publications by different associations and governments, annual reports and statements of companies, white papers and research publications by recognized industry experts and renowned academia etc. Paid data sources include third party authentic industry databases.
PRIMARY RESEARCH
Once data collection is done through secondary research, primary interviews are conducted with different stakeholders across the value chain like manufacturers, distributors, ingredient/input suppliers, end customers and other key opinion leaders of the industry. Primary research is used both to validate the data points obtained from secondary research and to fill in the data gaps after secondary research.
MARKET ENGINEERING
The market engineering phase involves analyzing the data collected, market breakdown and forecasting. Macroeconomic indicators and bottom-up and top-down approaches are used to arrive at a complete set of data points that give way to valuable qualitative and quantitative insights. Each data point is verified by the process of data triangulation to validate the numbers and arrive at close estimates.
EXPERT VALIDATION
The market engineered data is verified and validated by a number of experts, both in-house and external.
REPORT WRITING/ PRESENTATION
After the data is curated by the mentioned highly sophisticated process, the analysts begin to write the report. Garnering insights from data and forecasts, insights are drawn to visualize the entire ecosystem in a single report.
In-depth database
Our Report’s database covers almost all topics of all regions over the Globe..
Recognised publishing sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales support.
Safe & Secure
Complete secure payment process.
: sales@marketintelligencedata.com
: 1137 waynewood dr,Waxhaw NC 28173 ,United States
: +1 (704) 266-3234
